Drug Discovery and Development

Employees reveal highs and lows at 8 Big Pharma firms in 2024

By |

Female researcher

[Adobe Stock]

Ahead of our deeper Pharma 50 analysis of top pharma firms’ performance, this new 2024 analysis provides a timely snapshot of cultural and innovation metrics across eight of the leading Big Pharma firms. Looking closely at the pivotal issue of “Big Pharma work culture 2024,” we examine data and reviews from the employee site Glassdoor, the female employee resource InHerSight and insightful employee comments on the social media site Reddit.

To rank the pharmaceutical companies, we converted their Glassdoor overall ratings, benefits scores, recommendation rates, and InHerSight overall scores to a uniform scale out of 100, weighing the overall score, benefits, recommendation rate and InHerSight scores equally.

Merck comes in on top

Among the major pharmaceutical companies compared, Merck & Co. fared best with an overall score of 82.75. It was tied with J&J for the highest overall Glassdoor ranking. Merck was also the best-scoring Big Pharma in our analysis in 2023, that also included smaller firms. In the recent ranking, J&J was behind Merck & Co. with score of 82.0 and Roche Pharmaceuticals rounded out the top three with a score of 80.25. At the lower end of the spectrum, AbbVie and Bristol Myers Squibb tied at 73.0 for the lowest scores. In the middle, the scores were broadly similar: Pfizer (79.5), Novartis (77.5) and Sanofi (77.25). The full data are below. You may need to scroll to see data from all eight companies.

Filed Under: Drug Discovery and Development
Tagged With: , , , ,
 

About The Author

Brian Buntz

As the pharma and biotech editor at WTWH Media, Brian has almost two decades of experience in B2B media, with a focus on healthcare and technology. While he has long maintained a keen interest in AI, more recently Brian has made making data analysis a central focus, and is exploring tools ranging from NLP and clustering to predictive analytics.

Throughout his 18-year tenure, Brian has covered an array of life science topics, including clinical trials, medical devices, and drug discovery and development. Prior to WTWH, he held the title of content director at Informa, where he focused on topics such as connected devices, cybersecurity, AI and Industry 4.0. A dedicated decade at UBM saw Brian providing in-depth coverage of the medical device sector. Engage with Brian on LinkedIn or drop him an email at bbuntz@wtwhmedia.com.

Related Articles Read More >

Search Drug Discovery & Development